🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Phoenix
Start Date
2017-03-27
Trial ID
NCT03062540
Treatments Being Tested
The hypothesis of the current proposal is that chronic pioglitazone therapy...
Status
Terminated
Location
Mayo Clinic
Start Date
2006-03
Trial ID
NCT00586261
Treatments Being Tested
The purpose of this study is to assess the efficacy of two doses of subling...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00674700
This study is designed to determine if different doses of buprenorphine (ei...
Status
Terminated
Location
Erie County Medical Center
Start Date
2007-10
Trial ID
NCT00552578
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of three ...
Status
Completed
Location
National University Hospital - Allergy Unit 4222
Start Date
2008-10
Trial ID
NCT00901914
This is a multi-centre, randomised, placebo-controlled, double-blind, paral...
Status
Completed
Location
Japanese Red Cross Nagoya Daiichi Hospital
Start Date
2010-07
Trial ID
NCT01184859
Treatments Being Tested
Purpose of the study: • evaluate the efficacy and safety of Tenoten for ch...
Status
Completed
Location
Specialized Clinical Psychiatric Hospital # 1
Start Date
2010-07-28
Trial ID
NCT05605938
Treatments Being Tested
This is a 12-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Ashild Peters
Start Date
2019-03-07
Trial ID
NCT03841773
Treatments Being Tested
This is a 12-week study that will test the safety and efficacy of asenapine...
Status
Completed
Location
Multiple Locations
Start Date
2005-06-02
Trial ID
NCT00145470
This is a Phase 3 study designed to evaluate the safety and tolerability of...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-02
Trial ID
NCT02085135
Treatments Being Tested